共 50 条
- [31] A phase 2/3, randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of rimegepant for the preventive treatment of migraine [J]. HEADACHE, 2021, 61 : 98 - 99
- [34] A Phase 2/3, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Rimegepant for the Preventive Treatment of Migraine [J]. JOURNAL OF HEADACHE AND PAIN, 2021, 22 (SUPPL 1): : 19 - 19